---
title: CMC Pharmaceuticals, Inc. vs Codis
slug_a: cmcpharm
slug_b: codis
site: cdmo
review_signal_gate: closed
canonical_path: /compare/cmcpharm/codis
generated_by: BioBM Editorial AI
---

# CMC Pharmaceuticals, Inc. vs Codis

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

CMC Pharmaceuticals, Inc. (cmcpharm) is listed for cdmo. CMC Pharma provides integrated formulation development, analytical testing, stability studies, and cGMP manufacturing oversight for small molecule drug programs from preclinical through post-approval, with hands-on regulatory expertise and CMO management built in.

Services: 11. Modalities: 1. Indications: 0. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (11).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Codis (codis) is listed for cdmo. Global CDMO specializing in commercial-scale spray drying, amorphous solid dispersions, microencapsulation, and continuous granulation with 400,000 sq ft of GMP manufacturing across US and UK facilities.

Services: 8. Modalities: 1. Indications: 0. Locations: 5. Certifications: 2. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (8).

Review summary: Review summary withheld until site-level review gate opens.